# Oraverse Versus Laser

> **NCT05473858** · PHASE3 · RECRUITING · sponsor: **sara nabil** · enrollment: 36 (estimated)

## Conditions studied

- Reversal of Local Anesthesia in Children

## Interventions

- **DRUG:** OraVerse Injectable Product
- **DEVICE:** diode laser
- **OTHER:** Anaesthesia only

## Key facts

- **NCT ID:** NCT05473858
- **Lead sponsor:** sara nabil
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-10
- **Primary completion:** 2026-04-10
- **Final completion:** 2026-04-10
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05473858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05473858, "Oraverse Versus Laser". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05473858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*